Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$138.54 - $160.11 $166,248 - $192,132
-1,200 Reduced 25.0%
3,600 $576,000
Q2 2024

Aug 14, 2024

SELL
$137.2 - $150.79 $54,879 - $60,316
-400 Reduced 7.69%
4,800 $675,000
Q1 2024

May 15, 2024

BUY
$122.88 - $144.66 $258,048 - $303,786
2,100 Added 67.74%
5,200 $748,000
Q4 2023

Feb 14, 2024

BUY
$121.17 - $128.59 $169,638 - $180,026
1,400 Added 82.35%
3,100 $383,000
Q3 2023

Nov 14, 2023

BUY
$112.47 - $132.89 $56,235 - $66,445
500 Added 41.67%
1,700 $212,000
Q2 2023

Aug 14, 2023

BUY
$112.49 - $121.7 $11,249 - $12,170
100 Added 9.09%
1,200 $139,000
Q1 2023

May 15, 2023

BUY
$109.21 - $120.25 $21,842 - $24,050
200 Added 22.22%
1,100 $130,000
Q4 2022

Feb 14, 2023

BUY
$93.98 - $110.93 $84,582 - $99,837
900 New
900 $98,000

Others Institutions Holding ATR

About APTARGROUP, INC.


  • Ticker ATR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 65,337,000
  • Market Cap $10.4B
  • Description
  • AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps...
More about ATR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.